PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAG9. A total of 17 filers reported holding PDL BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $305,000 | – | 300,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SMH CAPITAL ADVISORS INC | 10,092,000 | $10,594,000 | 25.84% |
| Context Capital Management, LLC | 8,450,000 | $8,913,000 | 5.17% |
| Pinnacle Holdings, LLC | 3,170,000 | $3,327,834,000 | 1.24% |
| WHITEBOX ADVISORS LLC | 10,624,000 | $11,153,000 | 0.39% |
| WOLVERINE ASSET MANAGEMENT LLC | 16,852,000 | $17,720,000 | 0.23% |
| LINDEN ADVISORS LP | 13,617,000 | $14,364,000 | 0.22% |
| SG Americas Securities, LLC | 140,000 | $14,767,000 | 0.10% |
| LAZARD ASSET MANAGEMENT LLC | 18,585,000 | $19,603,000 | 0.03% |
| OAKTREE CAPITAL MANAGEMENT LP | 914,000 | $964,000 | 0.02% |
| Citadel Advisors | 31,733,000 | $33,394,000 | 0.02% |